Verition Fund Management LLC Regenxbio Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $347,322 - $437,630	20,158 New	20,158 $402,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $203,491 - $253,769	-6,269 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$33.61 - $49.95 $210,701 - $313,136	6,269 New	6,269 $213,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $119,561 - $301,406	-5,561 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $192,076 - $249,522	5,561 New	5,561 $228,000

193

42M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $458M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.